CLINICAL_TRIALS ClinicalTrials.gov record update

APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT06910358
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-08-22T00:04:42.205476+00:00
Published At: 2026-08-21T00:00:00+00:00
Record Updated At: 2026-08-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Erythropoietic Protoporphyria (EPP)", "X-Linked Protoporphyria (XLP)"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-08-21"
protocolSection.identificationModule.nctId: "NCT06910358"
protocolSection.identificationModule.officialTitle: "APOLLO: A Randomized, Double-Blind, Placebo-Controlled Study of Bitopertin to Evaluate the Efficacy, Safety, and Tolerability in Participants With Erythropoietic Protoporphyria (EPP) or X-Linked Protoporphyria (XLP)"
protocolSection.statusModule.overallStatus: "ACTIVE_NOT_RECRUITING"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.